Posts Tagged: "renal cell carcinoma"

Federal funding for a cancer moonshot is not a terrible idea

To hear Ars Technica say it is ”a terrible idea” to devote increased funding in order to eradicate cancer is astonishing on many levels. As part of the reason why he believes increased funding for cancer research is a terrible idea he explains that great strides have been made with respect to treatments and cures, which is true. Of course, it is also true that people are dying and they are dying horrible deaths. With the victories and advances that have been made over the last generation it is no longer fanciful to dream of a day when cancer can become eradicated. So why is it a terrible idea to devote more resources on a so-called cancer moonshot to attempt to once and for all put an end to this scourge? For anyone to call President Obama’s cancer moonshot a terrible idea is nothing short of cruel, and is frankly incredibly stupid.

Gene Quinn & Steve Brachmann

January 27, 2016

The University of Texas: Biomedical Innovation Focus

Many of the University of Texas’s medical developments involve the use of synthetic materials to aid in treating patients. One patent application would protect a scaffold for tissue engineering that biodegrades and delivers treatment over time. Another application describes a system of using nanoparticles to stimulate hyperthermia to treat tumors. A third application discusses an improved bioadhesive for sealing tissues together. Other notable patent application filings pertain to improved systems of diagnosing and treating diseases that usually cause a poor prognosis in patients. One patent application deals with a system of analyzing gene expressions to determine a patient’s susceptibility to renal cell carcinoma. A final application we feature provides for a more effective course of treatment for most gastrointestinal tract infections.

Steve Brachmann

September 17, 2013